Better together: McCann and FCB health chiefs talk strategy and strengths in creating IPG Health
With 39 agencies now under its collective umbrella, there aren’t many pharma marketing challenges that the new IPG Health can’t [...]
How one startup foretold the neuroscience renaissance after ’50 years of shitshow’
In the past couple of years, something curious has happened: Pharma and VC dollars started gushing into neuroscience research. Biogen’s [...]
Fight over “pay for delay” heats up in Washington
After being left to the courts for a decade, reverse settlement deals between generic and brand pharmaceutical companies, dubbed “pay [...]
Radar on Market Access: Executive Order Revives Standardized ACA Exchange Plans
In President Joe Biden’s new executive order aimed at promoting competition in the American economy, he directs HHS Secretary Xavier [...]
What is Expected growth in Health Economics & Outcomes Research (HEOR) Services Market Trends and Prospects 2027?
Global Health Economics & Outcomes Research (HEOR) Services 2020 by Manufacturers, Regions, Type and Application, Forecast to 2027 A new [...]
Health Care Buzz: What is a pre-existing condition and how does it work with insurance: Before and After the Affordable Care Act/Obamacare – Part 2
Save In part 1 of this 2- part series, we outlined the definition of a pre-existing condition. Definition: Most insurance [...]
Vizient Introduces Cost-Effective Direct-to-Employer Healthcare Solutions
Vizient recently launched its Direct to Employer Solutions, aimed at providing high quality healthcare while maintaining low costs. Vizient’s six [...]
Medical debt now outweighs all other personal debt in U.S. Those in Medicaid non-expansion states are hit the hardest
Although Americans’ overall medical debts have decreased in the decade since the Great Recession, medical bills now outweigh all other [...]
Drug companies overcharged NHS for hydrocortisone tablets
The CMA has imposed fines totalling over £260 million for competition law breaches in relation to the supply of hydrocortisone [...]
I-MAK Co-Founder Discusses How the COVID-19 Pandemic Shed Light on Racial Inequities and Using the Patent System to Reduce Drug Prices
Co-Founder and Executive Director of the Initiative for Medicines, Access & Knowledge (I-MAK) Priti Krishtel shares her thoughts on how [...]
How Drug Pricing Could Save The Infrastructure Deal
Democrats Look To Drug Spending To Rescue Infrastructure Deal Blocked from boosting revenues through enhanced Internal Revenue Service enforcement, congressional [...]
Biogen Controversy Highlights FDA’s Rules Surrounding Expert Panels
The Food and Drug Administration (FDA)’s approval of Biogen’s Aduhelm was based on shaky data. The resulting controversy continues to [...]
Surface Ophthalmics Announces $25 Million Private Round of Fundraising
Surface Ophthalmics Announces $25 Million Private Round of Fundraising |[21-July-2021]| Proceeds from the capital raise will help to support and [...]
Unforgivable Hypocrisy From FDAs Career CDER Leadership
The FDA leadership team’s hesitancy on Trump’s nCoV-2019 vaccines and hydroxychloroquine somehow didn’t apply to Biogen’s Aduhelm (aducanumab) review. The [...]
US Supreme Court to Consider Medicare Drug Pricing Challenge
The Supreme Court will consider a challenge brought forth by safety net hospitals. A Trump-era ruling leading to reduced drug [...]
Biden’s EO to Boost ‘Competitiveness’ Puts America at Disadvantage
President Biden recently unveiled a new executive order on “Promoting Competition” in the U.S. economy. Though the executive order is [...]
Register Today for IQVIA Institute Webinar on Using RWD in Oncology Clinical Trials
The IQVIA Institute for Human Data Science will host a webinar on Tuesday, August 17th at 10:00 AM EDT. Speakers [...]
Boston biotech’s drug for rare liver disease will cost $385,000 a year
The day after winning its first US drug approval, Boston biotech Albireo Pharma on Wednesday disclosed that its new medicine [...]
Prescription drugs are too expensive for many Americans. These companies are trying to change that
It's an experience millions of Americans have had: you go to the doctor, get a prescription, take it to the [...]
Synthetic data – A new solution solving historic healthcare privacy challenges
We have become all too accustomed – even desensitized – to reading stories of data breaches, misuse and evocative privacy [...]
The Digital Pills Market To Grow With Techno-Savvy Inputs
Persistence Market Research has come up with its latest finding in the form of “The Digital Pills Market” report, wherein [...]
Transforming the National Medicines Policy with a vision for the future
Australia’s National Medicines Policy (NMP) was launched 22 years ago. Since the NMP was first launched, Australia has seen significant [...]
Digital Health Tools Are Finding Business Models – IQVIA’s 2021 Read on the Health of Digital Health
In the Age of COVID, over 90,000 new health apps were released, as the supply of digital therapeutics and wearables [...]
Health Economics & Outcomes Research (HEOR) Services Market: Global Opportunity Analysis and Industry Forecast, 2020-2027
Health Economics & Outcomes Research (HEOR) Services Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Health Economics & Outcomes Research [...]
Pharma Rewards Democrat in Cash Following His Opposition of Pelosi’s Drug Pricing Bill
Representative Scott Peters was rewarded with large sums of cash donations to his campaign by pharma and lobbyists the day [...]